Literature DB >> 3323906

Biosynthesis and secretion of acid phosphatase by Leishmania donovani promastigotes.

P A Bates1, D M Dwyer.   

Abstract

Metabolic labeling and immunoprecipitation experiments demonstrated that soluble acid phosphatase (EC 3.1.3.2) was rapidly synthesized and released into culture medium by Leishmania donovani promastigotes. The kinetics of release indicated a constitutive secretory process (t 1/2 = 45 min). Moreover, acid phosphatase was the major secretory protein. The extracellular enzyme is composed of two heterodisperse bands of approximately 110 and 130 kDa in sodium dodecyl sulphate-polyacrylamide gels. It is synthesized as two intracellular precursors of 92.5 and 107 kDa which acquire the heterodisperse form characteristic of the mature extracellular enzyme during biosynthesis. Labeling in the presence of tunicamycin altered the electrophoretic mobility of the acid phosphatase, indicating the presence of several N-linked oligosaccharides on the mature enzyme. However, tunicamycin did not block secretion of the enzyme or its processing to the heterodisperse form. The biosynthetic effect of tunicamycin was mimicked by N-glycosidase F treatment of acid phosphatase immunoprecipitates. In contrast to tunicamycin, labeling in the presence of monensin inhibited processing of the phosphatase to its heterodisperse form. This indicates that Golgi processing, probably glycosylation, is responsible for the heterodispersity of the mature enzyme in sodium dodecyl sulphate-polyacrylamide gels. As with tunicamycin, monensin treatment did not prevent secretion of the acid phosphatase. These cumulative results demonstrate that release of this enzyme by L. donovani promastigotes occurs via a secretory pathway.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3323906     DOI: 10.1016/0166-6851(87)90081-8

Source DB:  PubMed          Journal:  Mol Biochem Parasitol        ISSN: 0166-6851            Impact factor:   1.759


  16 in total

1.  Trypanosoma cruzi-secreted vesicles have acid and alkaline phosphatase activities capable of increasing parasite adhesion and infection.

Authors:  Roberta F C Neves; Anne C S Fernandes; José R Meyer-Fernandes; Thais Souto-Padrón
Journal:  Parasitol Res       Date:  2014-06-07       Impact factor: 2.289

2.  Members of a unique histidine acid phosphatase family are conserved amongst a group of primitive eukaryotic human pathogens.

Authors:  Alison M Shakarian; Manju B Joshi; Mat Yamage; Stephanie L Ellis; Alain Debrabant; Dennis M Dwyer
Journal:  Mol Cell Biochem       Date:  2003-03       Impact factor: 3.396

3.  Leishmania mexicana promastigotes secrete a protein tyrosine phosphatase.

Authors:  Alma R Escalona-Montaño; Daniel Pardavé-Alejandre; Rocely Cervantes-Sarabia; Patricia García-López; Manuel Gutiérrez-Quiroz; Laila Gutiérrez-Kobeh; Ingeborg Becker-Fauser; Maria M Aguirre-García
Journal:  Parasitol Res       Date:  2010-04-20       Impact factor: 2.289

4.  A unique, highly conserved secretory invertase is differentially expressed by promastigote developmental forms of all species of the human pathogen, Leishmania.

Authors:  Todd A Lyda; Manju B Joshi; John F Andersen; Andrew Y Kelada; Joshua P Owings; Paul A Bates; Dennis M Dwyer
Journal:  Mol Cell Biochem       Date:  2015-03-13       Impact factor: 3.396

5.  Secreted acid phosphatase of Leishmania mexicana: a filamentous phosphoglycoprotein polymer.

Authors:  T Ilg; Y D Stierhof; R Etges; M Adrian; D Harbecke; P Overath
Journal:  Proc Natl Acad Sci U S A       Date:  1991-10-01       Impact factor: 11.205

6.  Purification and characterization of an 80-kilodalton membrane protein from Leishmania donovani.

Authors:  A C White; D McMahon-Pratt
Journal:  Infect Immun       Date:  1988-09       Impact factor: 3.441

7.  Human and murine immune responses to a novel Leishmania major recombinant protein encoded by members of a multicopy gene family.

Authors:  J R Webb; A Campos-Neto; P J Ovendale; T I Martin; E J Stromberg; R Badaro; S G Reed
Journal:  Infect Immun       Date:  1998-07       Impact factor: 3.441

Review 8.  Emerging therapeutic targets for treatment of leishmaniasis.

Authors:  Shyam Sundar; Bhawana Singh
Journal:  Expert Opin Ther Targets       Date:  2018-05-09       Impact factor: 6.902

9.  Comparisons of mutants lacking the Golgi UDP-galactose or GDP-mannose transporters establish that phosphoglycans are important for promastigote but not amastigote virulence in Leishmania major.

Authors:  Althea A Capul; Suzanne Hickerson; Tamara Barron; Salvatore J Turco; Stephen M Beverley
Journal:  Infect Immun       Date:  2007-07-02       Impact factor: 3.441

10.  Distribution of lipophosphoglycan-associated epitopes in different Leishmania species and in African trypanosomes.

Authors:  D L Tolson; L F Schnur; A Jardim; T W Pearson
Journal:  Parasitol Res       Date:  1994       Impact factor: 2.289

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.